altretamine has been researched along with Sarcoma 180 in 2 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
Sarcoma 180: An experimental sarcoma of mice.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lake, LM | 1 |
| Grunden, EE | 1 |
| Johnson, BM | 1 |
| Tricarico, M | 1 |
| Fuschiotti, P | 1 |
| Ricci, F | 1 |
| De Filippi, R | 1 |
| Nunziata, C | 1 |
| Pastore, S | 1 |
| De Vecchis, L | 1 |
2 other studies available for altretamine and Sarcoma 180
| Article | Year |
|---|---|
Toxicity and antitumor activity of hexamethylmelamine and its N-demethylated metabolites in mice with transplantable tumors.
Topics: Altretamine; Animals; Lethal Dose 50; Leukemia L1210; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL | 1975 |
Combined effects of host antitumor immune responses and chemotherapy. Studies with hexamethylmelamine.
Topics: Altretamine; Animals; Host vs Graft Reaction; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57B | 1988 |